NCT05747924
Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 1 / 2 recruiting NCT06547216
Phase 2 Open-label Extension Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 2 enrolling_by_invitation NCT05890833
The Risk of Falls Index for Patients With Neuromuscular Disorders No drug interventions Not Available Not Available completed NCT05272969
Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease No drug interventions Not Available Not Available recruiting NCT05902884
New Biomarkers in Facioscapulohumeral Muscular Dystrophy, Multispectral Optoacoustic Tomography. No drug interventions other Not Available recruiting NCT05409079
Schulze Muscular Dystrophy Ability Clinical Study No drug interventions treatment Not Available recruiting NCT04635891
Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) No drug interventions Not Available Not Available recruiting NCT02861911
Effects of NMES on Muscle Function of Patients With FSHD: a Double-blind Randomized Controled Clinical Trial No drug interventions supportive_care Not Available terminated NCT02622438
Routine Health Care of Patients With FSHD No drug interventions supportive_care Not Available recruiting NCT02159612
1 Year MRI Followup in Facioscapulohumeral Muscular Dystrophy No drug interventions Not Available Not Available completed NCT02159963
High Intensity Training in Patients With Facioscapulohumeral Muscular Dystrophy No drug interventions supportive_care Not Available completed NCT05548556
A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy No drug interventions treatment 2 active_not_recruiting NCT02603562
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Early Onset Facioscapulohumeral Muscular Dystrophy treatment 1 / 2 completed NCT05397470
Efficacy and Safety of Losmapimod in Treating Participants With Facioscapulohumeral Muscular Dystrophy (FSHD) (REACH) treatment 3 active_not_recruiting NCT04264442
Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE) treatment 2 active_not_recruiting NCT02239224
Safety, Tolerability, Pharmacokinetics, and Biological Activity of ATYR1940 in Adult Participants With Muscular Dystrophy treatment 1 / 2 completed NCT04003974
Efficacy and Safety of Losmapimod in Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 2 completed NCT01596803
Effects Antioxidants Supplementation on Muscular Function Patients Facioscapulohumeral Dystrophy (FSHD) No drug interventions supportive_care Not Available completed NCT02413190
Bone Health in Facioscapulohumeral Muscular Dystrophy No drug interventions Not Available Not Available completed NCT04267354
Arm Cycling in Facioscapulohumeral Dystrophy (FSHD) Patients No drug interventions treatment Not Available completed NCT06425445
Quantitative Assessment of Orofacial Muscle Function in FSHD No drug interventions other Not Available recruiting NCT05453461
ADVANCED FSHD-COM: New Clinical Outcome Measures to Evaluate Non-ambulant FSHD Patients, a Pilot Study No drug interventions other Not Available recruiting NCT02766985
Rasch-analysis of Clinical Severity in FSHD No drug interventions Not Available Not Available completed NCT02579239
Evaluate Safety and Biological Activity of ATYR1940 in Participants With Limb Girdle Muscular Dystrophy 2B (LGMD2B) and Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 1 / 2 completed NCT02625662
Facioscapulohumeral Dystrophy in Children No drug interventions Not Available Not Available completed NCT02927080
Study of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 2 terminated NCT00082108
Myotonic Dystrophy and Facioscapulohumeral Muscular Dystrophy Registry No drug interventions Not Available Not Available recruiting NCT03943290
Extension Study to Evaluate the Long-Term Effects of ACE-083 in Patients With Facioscapulohumeral Muscular Dystrophy (FSHD) and Charcot-Marie Tooth (CMT) Disease Types 1 and X (CMT1 and CMTX) treatment 2 terminated NCT01437345
A Multicenter Collaborative Study on the Clinical Features, Expression Profiling, and Quality of Life of Infantile Onset FSHD No drug interventions Not Available Not Available completed NCT00104078
Study Evaluating MYO-029 in Adult Muscular Dystrophy treatment 1 / 2 completed NCT03458832
Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD No drug interventions Not Available Not Available recruiting NCT05178706
Effectiveness of Upper Extremity Rehabilitation in pwFSHD (Patient With Facioscapulohumeral Dystrophia) No drug interventions Not Available Not Available completed NCT03123913
Study of Testosterone and rHGH in FSHD treatment 1 completed NCT02836418
Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Participants With Limb Girdle and Facioscapulohumeral Muscular Dystrophy (FSHD) treatment 1 / 2 completed NCT02531217
Safety, Tolerability, Pharmacokinetics (PK), and Activity of ATYR1940 in Participants With Muscular Dystrophy - Study Extension treatment 1 / 2 completed NCT05019625
Biomarker Development for Muscular Dystrophies No drug interventions Not Available Not Available recruiting NCT06086548
Unraveling Metabolic Involvement in Facioscapulohumeral Dystrophy Through Metabolomics No drug interventions Not Available Not Available not_yet_recruiting NCT00821548
Electrostimulation of Shoulder Girdle and Quadriceps Muscles in Facioscapulohumeral Muscular Dystrophy Patients No drug interventions treatment Not Available completed NCT01671865
Magnetic Resonance Imaging and Spectroscopy Biomarkers for Facioscapulohumeral Muscular Dystrophy No drug interventions Not Available Not Available active_not_recruiting NCT04001582
The United Kingdom Facioscapulohumeral Muscular Dystrophy Patient Registry No drug interventions Not Available Not Available recruiting NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT02032979
Neurological and Psychiatric Comorbidities Patients With FSHD 1 and 2 No drug interventions basic_science Not Available completed NCT06517498
Disease Burden and Living Situation of Patients With Facioscapulohumeral Muscular Dystrophy No drug interventions Not Available Not Available recruiting NCT04154098
Evaluation of a Textile Scapula Orthosis No drug interventions basic_science Not Available completed NCT00004685
Randomized Study of Albuterol in Patients With Facioscapulohumeral Muscular Dystrophy treatment Not Available completed NCT01970735
Clinical, Genetic and Epigenetic Characterization of Patients With FSHD Type 1 and FSHD Type 2 No drug interventions basic_science Not Available completed NCT06227182
Magnetic Resonance Imaging and Ultrasound Comparison With Load Evaluation No drug interventions Not Available Not Available recruiting NCT01116570
Physical Training Introduction in Lifestyle of Facioscapulohumeral Dystrophy Patients No drug interventions treatment Not Available completed NCT04999735
Digital Biotyping of FSHD Patients and Controls No drug interventions Not Available Not Available completed NCT01689480
Prospective Study for 24-months of Physical Training Introduced in Lifestyle of Patients With FSHD : Tolerance, Sustainability and Efficiency of Unsupervised Training Program. No drug interventions Not Available Not Available completed